Qube Research & Technologies LTD Aerie Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $1.41 Million - $3.37 Million	221,266 New	221,266 $3.35 Million
Q1 2022 May 09, 2022	SELL	$5.64 - $9.8 $122,940 - $213,620	-21,798 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$7.02 - $13.33 $153,021 - $290,567	21,798 New	21,798 $153,000
Q2 2021 Aug 13, 2021	SELL	$15.16 - $18.97 $194,336 - $243,176	-12,819 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $168,185 - $267,917	12,819 New	12,819 $229,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.